MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字H20243303

March 5, 2024

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

按C₁₃H₂₁NO₃计 3ml:1.25mg

化学药品

March 5, 2024

Company Information

Applicant Company

苏州工业园区桑田街218号生物医药产业园二期11号楼

Manufacturing Company

苏州工业园区桑田街218号生物医药产业园二期11号楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath